The Medicines (Products for Human Use) (Fees) Regulations 2010 PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download The Medicines (Products for Human Use) (Fees) Regulations 2010 PDF full book. Access full book title The Medicines (Products for Human Use) (Fees) Regulations 2010 by Great Britain. Download full books in PDF and EPUB format.
Author: Great Britain
Publisher:
ISBN: 9780111494547
Category : Law
Languages : en
Pages : 76
Get Book Here
Book Description
Enabling power: Medicines Act 1971, s. 1 (1) (2) & European Communities Act 1972, s. 2 (2) & Finance Act 1973, s. 56 (1) (2). Issued: 04.03.2010. Made: 26.02.2010. Laid: 04.03.2010. Coming into force: 01.04.2010. Effect: S.I. 1994/105; 2004/1031 amended & S.I. 2009/389 revoked with savings. Territorial extent & classification: E/W/S/NI. General
Author: Great Britain
Publisher:
ISBN: 9780111494547
Category : Law
Languages : en
Pages : 76
Get Book Here
Book Description
Enabling power: Medicines Act 1971, s. 1 (1) (2) & European Communities Act 1972, s. 2 (2) & Finance Act 1973, s. 56 (1) (2). Issued: 04.03.2010. Made: 26.02.2010. Laid: 04.03.2010. Coming into force: 01.04.2010. Effect: S.I. 1994/105; 2004/1031 amended & S.I. 2009/389 revoked with savings. Territorial extent & classification: E/W/S/NI. General
Author:
Publisher:
ISBN: 9780111520697
Category :
Languages : en
Pages :
Get Book Here
Book Description
Author: Great Britain
Publisher:
ISBN: 9780111474969
Category : Law
Languages : en
Pages : 72
Get Book Here
Book Description
Enabling power: Medicines Act 1971, s. 1 (1) (2) & European Communities Act 1972, s. 2 (2) & Finance Act 1973, s. 56 (1) (2). Issued: 05.03.2009. Made: 23.02.2009. Laid: 05.03.2009. Coming into force: 01.04.2009. Effect: S.I. 1994/105; 2003/2321 amended & S.I. 2008/552 revoked with savings. Territorial extent & classification: E/W/S/NI. General. Revoked by S.I. 2010/551 (ISBN 9780111494547) with savings
Author: Northern Ireland
Publisher:
ISBN: 9780337987472
Category :
Languages : en
Pages : 78
Get Book Here
Book Description
Author: Great Britain
Publisher:
ISBN: 9780111489109
Category : Law
Languages : en
Pages : 16
Get Book Here
Book Description
Enabling power: Medicines Act 1971, s. 1 (1) (2) & European Communities Act 1972, s. 2 (2) & Finance Act 1973, s. 56 (1) (2). Issued: 10.12.2009. Made: 07.12.2009. Laid: 10.12.2009. Coming into force: 01.01.2010. Effect: S.I. 1994/3144; 2009/389 amended. Territorial extent & classification: E/W/S/NI. General
Author: Great Britain
Publisher:
ISBN:
Category : Administrative law
Languages : en
Pages : 2244
Get Book Here
Book Description
Author: Great Britain
Publisher:
ISBN:
Category : Law
Languages : en
Pages : 1512
Get Book Here
Book Description
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309498635
Category : Medical
Languages : en
Pages : 169
Get Book Here
Book Description
Globalization is rapidly changing lives and industries around the world. Drug development, authorization, and regulatory supervision have become international endeavors, with most medicines becoming global commodities. Drug companies utilize global supply chains that often include facilities in countries with inconsistent regulations from those of the United States, perform pivotal trials in multiple countries to support registration submissions in various jurisdictions, and subsequently market their medicines throughout most of the world. These companies operate across borders and require individual national regulators to ensure that drugs authorized for use in their countries are safe and effective, and appropriate for their health care system and their population. This process involves significant resources and often duplicative work. It is important to consider how this process can be improved in order to better allocate resources, time, and efforts to improve public health. Regulating Medicines in a Globalized World: The Need for Increased Reliance Among Regulators considers the role of mutual recognition and other reliance activities among regulators in contributing to enhancing public health. This report identifies opportunities for leveraging reliance activities more broadly in order to potentially impact public health globally. Key topics in this report include the job of medicines regulators in today's world, what policy makers need to know about today's regulatory environment, stakeholder views of recognition and reliance, as well as removing impediments and facilitating action for greater recognition and reliance among regulatory authorities.
Author: American Bar Association. House of Delegates
Publisher: American Bar Association
ISBN: 9781590318737
Category : Law
Languages : en
Pages : 216
Get Book Here
Book Description
The Model Rules of Professional Conduct provides an up-to-date resource for information on legal ethics. Federal, state and local courts in all jurisdictions look to the Rules for guidance in solving lawyer malpractice cases, disciplinary actions, disqualification issues, sanctions questions and much more. In this volume, black-letter Rules of Professional Conduct are followed by numbered Comments that explain each Rule's purpose and provide suggestions for its practical application. The Rules will help you identify proper conduct in a variety of given situations, review those instances where discretionary action is possible, and define the nature of the relationship between you and your clients, colleagues and the courts.
Author: Emily Jackson
Publisher: Bloomsbury Publishing
ISBN: 1847319092
Category : Law
Languages : en
Pages : 308
Get Book Here
Book Description
The principal purpose of this book is to tell the story of a medicine's journey through the regulatory system in the UK, from defining what counts as a medicine, through clinical trials, licensing, pharmacovigilance, marketing and funding. The question of global access to medicines is addressed because of its political importance, and because it offers a particularly stark illustration of the consequences of classifying medicines as a private rather than a public good. Two further specific challenges to the future of medicine's regulation are examined separately: first, pharmacogenetics, or the genetic targeting of medicines to subgroups of patients, and second, the possibility of using medicines to enhance well-being or performance, rather than treat disease. Throughout, the emphasis is on the role of regulation in shaping and influencing the operation of the medicines industry, an issue that is of central importance to the promotion of public health and the fair and equitable distribution of healthcare resources.
